Doug Besch Optimize Rx Corp (OPRX) insider trading activity

OPRX Quotes by TradingView

Doug Besch is Chief Product Officer of OptimizeRx Corp. Currently has a direct ownership of 11,583 shares of OPRX, which is worth approximately $56,872. The most recent transaction as insider was on Dec 19, 2024, when has been sold 577 shares (Common Stock) at a price of $4.75 per share, resulting in proceeds of $2,740. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 11.6K
47.59% 3M change
201.01% 12M change
Total Value Held $56,872

Doug Besch Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 19 2024
SELL
Payment of exercise price or tax liability
$2,740 $4.75 p/Share
577 Reduced 4.75%
11,583 Common Stock
Dec 19 2024
BUY
Exercise of conversion of derivative security
-
1,964 Added 13.91%
12,160 Common Stock
Oct 03 2024
SELL
Payment of exercise price or tax liability
$7,642 $7.83 p/Share
976 Reduced 8.74%
10,196 Common Stock
Oct 03 2024
BUY
Exercise of conversion of derivative security
-
3,324 Added 22.93%
11,172 Common Stock
Feb 15 2024
BUY
Grant, award, or other acquisition
-
4,000 Added 33.76%
7,848 Common Stock
Oct 03 2023
SELL
Payment of exercise price or tax liability
$6,890 $7.06 p/Share
976 Reduced 20.23%
3,848 Common Stock
Oct 03 2023
BUY
Exercise of conversion of derivative security
-
3,324 Added 40.8%
4,824 Common Stock
DB

Doug Besch

Chief Product Officer
Rochester, MI

Track Institutional and Insider Activities on OPRX

Follow OptimizeRx Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OPRX shares.

Notify only if

Insider Trading

Get notified when an Optimize Rx Corp insider buys or sells OPRX shares.

Notify only if

News

Receive news related to OptimizeRx Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on OPRX